Graft Failure

• CLINICAL_TRIALS trial_result · 2025-12-31
  Clinical Trial Update: Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy [Phase 2]

  A completed Phase 2 trial evaluated the safety of anti-IL-6 receptor antibodies to reduce allo-sensitization after kidney allograft nephrect…

• CLINICAL_TRIALS trial_result · 2025-10-08
  Clinical Trial Update: Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen [Phase 2]

  Phase II study evaluating whether tacrolimus extended-release tablets are as effective as standard twice-daily tacrolimus dosing in heart tr…

• CLINICAL_TRIALS trial_result · 2025-09-30
  Clinical Trial Update: RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation [Phase 2]

  This Phase 2 trial update reports termination of a study evaluating eltrombopag to reverse poor graft function after allogeneic hematopoieti…

• CLINICAL_TRIALS trial_result · 2025-06-05
  Clinical Trial Update: Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients

  A completed pediatric hematopoietic stem cell transplant trial assessing how tacrolimus blood concentration relates to transplant-related ou…

• CLINICAL_TRIALS trial_result · 2019-01-23
  Clinical Trial Update: Silver Graft All Comers Registry

  Completed status reported for the Silver Graft All Comers Registry sponsored by B. Braun Melsungen AG, tracking aneurysm cases and graft-rel…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2018-12-12
  Clinical Trial Update: A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients [Phase 2]

  Phase 2 trial evaluating plerixafor/G-CSF as conditioning agents before TCR alpha/beta depleted HSCT in patients with Wiskott-Aldrich Syndro…

• CLINICAL_TRIALS trial_result · 2015-05-27
  Clinical Trial Update: Induction of HO-1; a Therapeutic Approach to Reduce Ischaemia Reperfusion Injury (IRI) Following Deceased Donor Renal Transplantation [Phase 3]

  Phase 3 trial update evaluating induction of heme oxygenase-1 to reduce ischemia-reperfusion injury and graft failure after deceased donor r…